Medical and Clinical Services Opportunities
Showing 21 opportunities in Medical and Clinical Services
Physiotherapy Services for Sydney Trains - Doc5590882943
Physiotherapy Services for Sydney Trains - Doc5590882943
AustraliaSCM2231 Employment Related Medical Services Prequalification Scheme
SCM2231 Employment Related Medical Services Prequalification Scheme
AustraliaPQQ Specialised psychological and wellbeing support services
Austin Health is seeking suitability qualified and experienced Supplier(s) to deliver specialised psychological and wellbeing support services (SPWSS) to our workforce to complement an EAP/CIR service and is pleased to invite you to respond to this PQQ. The aim of the questionnaire is to: • Identify suppliers with experience in delivering this neiche services to a large metro tertiary healthcare service • Identify the number of suitable suppliers in the Australian market • Understand the indicative costs • Understand different service models that will help develop the scope for our future ITS • Understand suppliers proposed resourcing structures for this type of project Following the evaluation of the PQQ submissions, suitable suppliers may be shortlisted and invited to respond to a formal Invitation to Supply (ITS). Further information on this next market engagement will be shared with these shortlisted suppliers.
AustraliaAnalytical Laboratory Services for AMRA 2026-2029
Dairy Food Safety Victoria (DFSV) is seeking submissions from laboratory service providers to provide analytical testing services for the Australian Milk Residue Analysis (AMRA) Survey. The analytes covered in the survey include a range of veterinary, agricultural chemicals and environmental contaminants in raw cow's milk. Suitably qualified laboratories will be required to have NATA accredited test methods, meet method performance parameters and the ability to demonstrate satisfactory performance. The services required include: - analyse raw milk samples - provide certificate of analysis (CoA) - issue bi-monthly electronic reports of samples pending and reported. DFSV is a statutory authority established by the Victorian Parliament under the Dairy Act 2000. As the independent food safety regulator of Victoria's dairy industry, DFSV's role is to ensure that national food safety standards are met through licensing all dairy businesses operating in Victoria and ensuring compliance with their food safety program. DFSV co-ordinate the AMRA Survey on behalf of the Australian Government, Department of Agriculture, Fisheries and Forestry.
AustraliaPRN22-447 Provision of Toxicology Services to Court Services Victoria
Court Services Victoria (CSV) is a body corporate established by the Court Services Victoria Act 2014 (Vic) to provide the administrative services and facilities necessary for Victoria’s courts and tribunals to operate independently of the direction of the executive branch of government. CSV is seeking responses for the provision of Toxicology Services to support court mandated drug testing across the Magistrates’ Court, Children’s Court, and County Court of Victoria for a duration of up to seven years, consisting of a fixed term of 3 years with 2 options (2 years each) at the discretion of CSV. The proposed Part C Contract is a Standing Offer Agreement, under which CSV can issue contract Purchase Orders for each of the Magistrates Court of Victoria, the Children’s Court of Victoria and the County Court of Victoria. This will create separate Purchase Order Contracts for those jurisdictions. CSV is adopting this approach for ease of contract management, as invoicing and reporting will be required separately for each jurisdiction. Toxicology Services are a critical component of Drug and Alcohol Treatment Orders (DATOs) at MCV and CCV, Family Drug Treatment Court (FDTC) at ChCV, and other therapeutic interventions. Drug and alcohol testing is the primary mechanism used to monitor participant progress and compliance with a DATO in accordance with the Adult Treatment Court Best Practice Standards and Section 18X(1) of The Sentencing Act 1991 (Vic). Accordingly, access to timely and accurate results is critical to facilitating the judicial monitoring requirements of a DATO and achieving therapeutic outcomes for program participants. Participants are subject to regular urinalysis testing, often multiple times per week, with results informing judicial decisions and case reviews. The services must comply with updated standards such as AS/NZS 4308:2023 and include testing for a broader range of substances, including Ethyl Glucuronide (EtG), Gamma-Hydroxybutyrate (GHB), Ketamine, and synthetic cannabinoids. The scope of this RFT includes both onsite sample collection and offsite laboratory testing services. The services include: Onsite Collection : At Melbourne Therapeutic Recovery Centre (350 Queen Street, Melbourne), Dandenong, Ballarat, Shepparton and any other locations as deemed necessary by Courts Group, with staffing levels ranging from 1–3 collectors per site. Offsite Collection : At the supplier’s community-based in-clinic collection facilities managed and resourced by the supplier throughout metropolitan Melbourne including Shepparton. Laboratory Testing: Compliance with AS/NZS 4308:2023 for urine drug screening, including testing for EtG, GHB, Ketamine, synthetic cannabis and fentanyl based, and other substances as directed by the courts. Turnaround Times: Results within 24 hours for screening tests and 48 hours for confirmations or additional substances. Results Communication : The Service Provider will be required to provide the results by a web-based method such as a portal. Service Availability : 360 days per year, excluding public holidays. The end result of this procurement process will be a Services Agreement with a sole service provider where each court will request Services under the Contract. For further details, please refer to the attachments.
AustraliaSupply of Cardiac Catheterisation Laboratory Custom Packs
Austin Health is seeking a supplier for the supply of three Cardiac Catheterisation Laboratory custom packs, to replace the current contract expiring 30 September 2026. The proposed contract term is three years and three months, commencing from 1 October 2026 and ending on 31 December 2029.
AustraliaVictorian Stroke Telemedicine Equipment, Management and Support Services
Ambulance Victoria is seeking the supply of Victorian Stroke Telemedicine (VST) Equipment, Management and Support Services. The purpose of this RFT is to engage the market to select a suitably qualified and experienced provider to supply telemedicine software and hardware equipment under a contractual arrangement that includes management and support services of the products. The tender requirements will include, in part, a mandatory selection criterion in the Specification, due to the specialised nature of the equipment. Request documentation will require Tenderers to provide costings for a lease and outright purchase. Installation of the equipment will be required at 22 sites across Victoria, Tasmania and New South Wales (Australia). The Contractor will provide installation, training, and ongoing education of hospital and VST personnel.
AustraliaClinical Advisory Services Register
The TAC’s Clinical Advisory Services Register provides the TAC access and flexibility to engage highly experienced and qualified allied health and medical professionals for best-practice and specialist clinical advice across a wide range of disciplines. The register ensures the TAC is enabled to support the Make Every Day Matter Strategy by using suppliers for both internal claims advice as well as providing clinical input into strategic initiatives. Clinical Advisory Services supports the TAC’s internal claims management process by providing independent clinical reviews and advice on a referral basis. Clinical reviews are focused on ensuring that treatment is evidence informed and clinically justified. The TAC is seeking applications from individual and intermediary Suppliers capable of providing Clinical Advisory Services or Senior Clinical Advisory Services under the Register. Services include: Claims advice and Client outcomes; Business advice; and Sector Engagement. A detailed description of Service and clinical disciplines being sought via the Register can be found in the Service Specification (and attachments) included as part of the Register pack below: Invitation to Register (Individual) - for single applicants i.e. providing only one Clincial Advisor Invitation to Register (Multiple) - for applicants providing more than one Clinical Advisor Privacy Questionnaire Service Specification Service Specification (Annex A) - Service Standards Service Specification (Annex B) - Invoice Template Service Specification (Annex C) - Quality Review Framework Service Specification (Annex D) - Clinical Advisory Service Categories NOTE - Interested applicants may register as a supplier with Buying for Victoria to download the Register pack. To lodge your application, please follow the instructions detailed in the Invitation to Register.
AustraliaAssisted Reproductive Technology (ART) Storage Funding Program
The purpose of this grant opportunity is to support patients from two population groups who face extra costs associated with fertility preservation: people who require fertility treatment, including fertility preservation, due to a cancer diagnosis, and people at risk of passing on genetic conditions who have undergone pre-implantation genetic testing funded by the Medicare Benefit Schedule (MBS), as described in MBS items 13207, 73384, 73385, 73386 or 73387. Costs associated with the cryostorage of eggs, sperm or embryos are not currently subsidised through the Medical Benefits Schedule (MBS) and these patient groups often face extra costs associated with fertility preservation. The intended outcome of the program is to reduce eligible patient’s costs for preserving eggs, sperm, or embryos through cryostorage (freezing). Under the program, patients will be eligible for up to ten years of cryostorage funding per eligible material stored. To view the grant opportunity documents, please select the red Grant Opportunity Documents button on the left hand side.
AustraliaBulk Billing Practice Incentive Program
The Bulk Billing Practice Incentive Program (BBPIP) was announced as part of the 2025-26 Budget as a component of Outcome 2: Individual Health Benefits, Program 2.1 Medical Benefits of the department’s Portfolio Budget Statements 2025-26. Practices participating in BBPIP receive an additional 12.5% incentive payment on every $1 of the MBS benefits paid from eligible services, split evenly (50/50) between the GP and the practice. Participating practices must bulk bill every eligible MBS service (Outlined at Appendix 15.3 of the Grant Opportunity Guidelines) for all their Medicare-eligible patients to receive the incentive payment. Eligible MBS services include the most common GP services such as time-tiered consultation items, health assessments, mental health treatment items, and chronic condition management items. The BBPIP incentive payment is in addition to MBS benefits paid, and MBS BBIs are paid independently of the BBPIP incentive payments. BBPIP is managed by the Department of Health, Disability and Ageing (the department). Note: BBPIP registrations will not open until 1 November 2025. Please refer to the most recent version of the Grant Opportunity Guidelines (version 4) published 3 March 2026. To view the grant opportunity documents, please select the red "Grant Opportunity Documents" button on the left-hand side.
AustraliaComprehensive Primary Health Care - ACCHS Division of Service Delivery
The Comprehensive Primary Health Care (CPHC) Program is a component of the Indigenous Australians’ Health Programme (IAHP). The purpose of this grant opportunity is to allocate funding under the IAHP CPHC stream to select Aboriginal community-controlled health services (ACCHS) in local communities, previously serviced by existing ACCHS funded under the IAHP CPHC rolling funding arrangements. This grant opportunity will allow eligible organisations to demonstrate their capacity to provide a sustainable model of health care that will deliver high quality, culturally safe, multi- disciplinary, and integrated CPHC for First Nations people in their communities. An essential requirement of CPHC funding is that grantees must provide essential primary health care, which, includes general practice and clinical services delivered by suitably qualified medical professionals. Grantees have the flexibility to determine what other eligible services will be delivered in order to meet identified community health and wellbeing needs, and determine the appropriate workforce required to implement those services. Those services may include: • population health programs • activities that support the delivery of essential clinical services • improving access to antenatal care and child, maternal and family health services for First Nations children, their mothers and families • the prevention, detection and management of chronic diseases • investment in priority health areas in regions of high health need or population growth and • improving the clinical effectiveness of the health system and supporting sustainable, long-term service reform delivery and improvement through Continuous Quality Improvement (CQI). To view the grant opportunity documents, please select the red "Grant Opportunity Documents" button on the left-hand side.
AustraliaMRFF 2022 Frontier Health and Medical Research Grant Opportunity
This grant opportunity offers funding to support medical research and medical innovation programs of research that deliver a ‘moonshot’ by creating a treatment for a currently serious and incurable health condition, through a series of linked projects. The program of research can propose to develop novel health technologies and/or re?purpose existing health technologies in a novel way. The initial application process to secure funding through this grant opportunity will be conducted in two stages: expression of interest (EOI) – outlining a proposed program of research comprising of a series of linked projects with a 10-year time horizon full application, (invitation only – following EOI) for a project of up to 5 years under the program of research. Applicants may propose to commence research at any stage in the research pipeline from proof-of-concept, with the intention of achieving full implementation of the proposed technology in 10 years. Funding for subsequent projects under the program of research that continue to progress the technology towards full implementation can be sought by submitting additional full applications to this grant opportunity (i.e. applicants do not need to recommence with an EOI). These applications may be submitted by invitation only. We expect that expressions of interest will close on 31 March 2027, with the last grants awarded by 30 June 2028.
AustraliaMRFF – Clinical Trials Activity Initiative – 2026 International Clinical Trial Collaborations Grant Opportunity
The Medical Research Future Fund (MRFF) Clinical Trials Activity Initiative (the Initiative) aims to increase clinical trial activity in Australia in order to improve the evidence base supporting clinical care and to help patients access trials relevant to their health circumstances and enable researchers to bring international trials to Australian patients. The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: Promote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia. Provide high-quality evidence of the effectiveness of novel health treatments, drugs or devices in ‘usual care’ settings, which will support a decision on whether to deliver the intervention in an Australian setting. The intended outcome of the research is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality, evidence-based and effective health care. Applicants to this grant opportunity must propose a clinical trial in Australia in collaboration with international counterparts. The clinical trial should not have commenced recruitment at the Australian trial site/s. Please note the 2026 MRFF International Clinical Trial Collaborations grant opportunity will be open for one round only. This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health, Disability and Ageing. Further information on the Medical Research Future Fund is available from the Department of Health, Disability and Ageing's website. A list of Eligible Organisations can be found on the NHMRC List of MRFF Eligible Organisations webpage
AustraliaMRFF – Genomics Health Futures Mission – 2026 Genomics Health Futures Grant Opportunity
The objective of this GO is to provide grants of financial assistance to support medical research and medical innovation projects that: Stream 1 (TCR): develop genomic tools and technologies to identify genetic predisposition to cancer and improve screening and targeted intervention. Focus on increased access to genomic testing and on liquid biopsy. Stream 2 (TCR): conduct scalable research to enhance novel gene discoveries, increase diagnostic rates and enable disease modelling to support development of targeted therapies or prevention strategies. Stream 3 (Incubator): develop novel methods for using polygenic risk scores to identify subgroups of the population at high risk of common and complex diseases. -Topic A: Cardiovascular disease -Topic B: Diabetes -Topic C: Other common and/or complex diseases Stream 4 (Incubator): develop novel methods for improving accuracy and usefulness of polygenic risk scores to stratify people with common cancers for surveillance and treatment. -Topic A: Breast Cancer -Topic B: Colorectal cancer -Topic C: Prostate cancer -Topic D: Other common cancers Stream 5 (TCR): undertake research to enhance or streamline uptake of clinical genomics into practice. Stream 6 (Accelerator): develop and maintain infrastructure to support research collaboration by enabling data sharing, portability, longevity and connectivity of analysis across Australia. Research conducted should address emerging ethical, legal and social issues associated with the governance of clinical and genomic datasets with particular focus on the application of advanced analytics (e.g. AI) to enhance the diagnostic utility of genomics. Applicants must propose research that addresses these objectives and those of the Genomics Health Futures Mission as outlined in the Roadmap and Implementation Plan. This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health, Disability and Ageing. Further information on the MRFF is available here.
AustraliaMRFF – Preventive and Public Health Research Initiative – 2026 Consumer-Led Research Grant Opportunity
The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: Stream 1 (Incubator): identify health priorities, develop new approaches and/or methodologies and conduct pilot studies addressing health issues and/or barriers that: are co-led, co-produced and/or co-designed with consumers are in partnership with health services increase consumers’ understanding of, and involvement in, research. Stream 2 (Targeted Call for Research): develop and/or test scalable and sustainable approaches, in partnership with consumers, that enable self-care interventions or improve quality of life and/or survivorship care. Approaches are for individuals from one or more priority populations, who have experienced or are experiencing long-term diseases and conditions. Approaches may, where appropriate, also deliver for the individual’s families, carers and communities. Topic A: Research projects that focus on cancer Topic B: Research projects that focus on long term physical diseases and conditions other than cancer Topic C: Research projects that focus on mental health challenges, diseases or conditions. Applicants to this grant opportunity must propose research that delivers against the above objectives and those of the Preventive and Public Health Research Initiative. This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health, Disability and Ageing. Further information on the Medical Research Future Fund is available from the Department of Health, Disability and Ageing's website. A list of Eligible Organisations can be found on the NHMRC List of MRFF Eligible Organisations webpage.
AustraliaMRFF 2026 BioMedTech Incubator
The 2026 BioMedTech Grant Opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative. This opportunity looks to fund suitable organisations to identify, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects that have commercial potential. The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers, diagnostics, therapeutics, assistive devices and/or digital technologies that have progressed through the early stages of research and development to the point where they are 'de-risked' and attractive to private investment for commercialisation. Applicants may propose to support development of innovations in their area/s of strength (i.e. applicants are not required to propose a program that covers the breadth of the biomedtech sector).
AustraliaMRFF – Traumatic Brain Injury Mission – 2026 Traumatic Brain Injury Grant Opportunity
The Medical Research Future Fund (MRFF) Traumatic Brain Injury (TBI) Mission aims to enable or support research designed to improve the lives of all Australians who experience a TBI. The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: Stream 1 (Priority area 2.1, Targeted Call for Research): test the efficacy and complete a process evaluation of novel treatments, clinical indicators and/or interventions for moderate to severe TBI in reducing time spent in acute care and/or improving long-term patient outcomes. Stream 2 (Priority area 2.3, Targeted Call for Research): conduct research to support effective national adoption and best practice use of clinical guidelines and protocols for mild TBI, including integration of prognostic and predictive approaches, and assessing and addressing barriers to implementation and inequalities including in all of: - Aboriginal and Torres Strait Islander people - People affected by family, domestic and sexual violence - Older people - Rural, regional and remote populations in geographically diverse areas - Culturally and linguistically diverse populations The intended outcome of the research is to improve the health and wellbeing of Australians by: Stream 1: improving acute care and/or long term outcomes for moderate to severe TBI. Stream 2: improving uptake of and access to best practice care for people with mild TBI. Applicants to this grant opportunity must propose research that addresses one of the two Streams of research. This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health, Disability and Ageing. Further information on the Medical Research Future Fund is available from the Department of Health, Disability and Ageing's website. A list of Eligible Organisations can be found on the NHMRC List of MRFF Eligible Organisations webpage.
AustraliaCancer Genomics Clinical Trials Fund: SCCT Program
The Cancer Genomics Clinical Trials Fund (the Fund) is a one-off grant opportunity that will run over three years, FY2025-26 through to FY2027-28. The Fund will direct additional investment to Australia's Multi-site Collaborative Cancer Clinical Trials Groups (CTGs) under the Support for Cancer Clinical Trials (SCCT) program to build capacity and develop approached of methods to set the foundation for, and accelerate the incorporation of genomics into the design of cancer clinical trial concepts and protocols to benefit all CTGs. For further information please refer to the Cancer Genomics Clinical Trials Fund Grant Opportunity Guidelines.
Australia2026 NHMRC e-ASIA Joint Research Program funding commencing 2027
The NHMRC e-ASIA Joint Research Program supports Australian participation and collaboration in leading international research through the e-ASIA Joint Research Program (e-ASIA JRP). The e-ASIA JRP supports international joint research projects in the East Asia region. The e-ASIA JRP selects research projects through an open call for proposals. Fields of cooperation are decided among the e-ASIA participating member organisations and funding is for up to three years. The 2026 NHMRC e-ASIA Joint Research Program grant opportunity will support Australian participation and partnership in international collaborative research through the e-ASIA JRP 15th call for proposals in Health Research stream under the following topics: • Infectious disease and immunology • Advanced medical research and enabling technologies Further information on the e-ASIA JRP 15th Health Research call is available from the e-ASIA website
AustraliaMRFF – CTA Initiative – 2025 Clinical Trials Activity Grant Opportunity
The Medical Research Future Fund (MRFF) Clinical Trials Activity Initiative aims to: improve the evidence base supporting clinical care help patients access trials relevant to their health circumstances enable researchers to bring international trials to Australian patients. The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: Stream 1 (Incubator): conduct a pilot study to assess the feasibility of a new clinical trial for one or more treatments and/or management strategies for a rare cancer, rare disease and/or unmet need. Stream 2 (Targeted Call for Research): conduct a clinical trial of one or more treatments and/or management-based interventions for rare cancers, rare diseases and/or unmet need. Stream 3 (Targeted Call for Research): conduct a clinical trial that supports the delivery of effective and high value care by targeting evidence gaps of value to health technology assessment processes in Australia. Stream 4 (Targeted Call for Research): conduct a prevention clinical trial aimed at reducing the risk, onset or progression of disease through early intervention strategies. The intended outcome of the research is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality, evidence-based and effective health care. Applicants to this grant opportunity must propose research that addresses one of the four Streams of research. This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health, Disability and Ageing. Further information on the Medical Research Future Fund is available fromthe Department of Health, Disability and Ageing's website. A list of Eligible Organisations can be found on the NHMRC List of MRFF Eligible Organisations webpage
AustraliaAdministration of the Insulin Pump Program
The program administrator will be engaged to provide administrative services to the Insulin Pump Program (IPP). The IPP is an ongoing Commonwealth program that provides fully subsided insulin pumps to eligible Participants. The successful Tenderer appointed will be required to: Manage an efficient application process, including assessment of eligibility and management of possible wait lists. Manage a database of applicants and Participants of the Program. Develop stakeholder communication and engagement strategies, including administering a program website. Establish formal relationships with the insulin pump panel supplier/s that supports the efficient ordering and delivery of insulin pumps to eligible Participants. Collect relevant information to monitor the effectiveness of the program. Conduct Quality of Life surveys of Participants. Meet Department reporting requirements.
AustraliaNever Miss an Opportunity
Get instant notifications for new opportunities that match your criteria. Track deadlines and manage applications in one place.
Start Free Trial